Trump has good evidence money can be saved by cracking down on insurance industry: Former Cigna VP
Wendell Potter, former Cigna VP, joins 'Money Movers' to discuss how to explain what the DOJ's considering around UnitedHealth, the DOJ's history with solutions, and much more.
Cigna Is A Buy: Market Overreaction Creates A Big Opportunity
Cigna looks undervalued at under 10x earnings, with strong growth potential. Evernorth continues to expand, adding to the company's long-term value. Large stock buybacks are supporting earnings per share and investor returns.
Cigna Misses EPS: What It Means for the Health Insurance Industry
Leading health insurer Cigna Group Inc. NYSE: CI was praised for having the foresight to divest its Medicare Advantage (MA) business before rising acute care utilization rates would impact its medical care ratio (MCR) or medical benefits ratio (MBR), which the percentage of medical premiums paid out for medical reimbursement claims.
Health insurer Cigna says it will simplify claims process amid scrutiny
Cigna will roll out measures to simplify the process for physicians to submit claims and prior authorization requests, the U.S. health insurer said on Monday.
Why Cigna Stock Is Plummeting Today
Shares of Cigna (CI -7.49%) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m.
Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership
CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum of $29.50, which indicates growth of at least 7.9% from the 2024 figure.
The Cigna Group (CI) Q4 2024 Earnings Call Transcript
The Cigna Group (NYSE:CI ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants David Cordani - Cigna Group's Chairman, Chief Executive Officer Brian Evanko - Chief Financial Officer of Cigna Group, President, Chief Executive Officer of Cigna Healthcare Eric Palmer - President, Chief Executive Officer of Evernorth Health Services Ralph Giacobbe - Senior Vice President of Investor Relations Conference Call Participants Justin Lake - Wolf Research Stephen Baxter - Wells Fargo Charles Rhyee - TD Cowen Lisa Gill - JP Morgan AJ Rice - UBS Scott Fidel - Stephens Erin Wright - Morgan Stanley Andrew Mok - Barclays Josh Raskin - Nephron Research Adam Ron - Bank of America Ann Hynes - Mizuho Security Sarah James - Cantor Fitzgerald Ben Hendrix - RBC Capital Markets George Hill - Deutsche Bank Operator Ladies and gentlemen, thank you for standing by for the Cigna Group's Fourth Quarter 2024 Results Review. At this time all callers are in a listen-only mode.
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cigna (CI) Lags Q4 Earnings Estimates
Cigna (CI) came out with quarterly earnings of $6.64 per share, missing the Zacks Consensus Estimate of $7.83 per share. This compares to earnings of $6.79 per share a year ago.
Cigna misses quarterly profit estimates on higher medical costs
Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.
Cigna 2024 Profits Eclipse $3 Billion Despite Rising Costs
The Cigna Group Thursday reported more than $3.4 billion in 2024 net income including $1.4 billion in the fourth quarter as the health insurer worked to overcome rising medical expenses in its employer plans.
Cigna to take steps to lower out-of-pocket costs of prescription drugs
Cigna's unit Evernorth Health said on Wednesday it will take several steps to help lower out-of-pocket cost of prescription drugs for patients at its pharmacy stores.
